CPIXCumberland Pharmaceuticals Inc.

7.650USD0.00%Mkt Cap: 114.62M $P/E:

Cumberland Pharmaceuticals Inc., a specialty pharmaceutical company, focuses on the acquisition, development, and commercialization of prescription products. The company offers Acetadote, an injection for the treatment o…

HeadlineSourceTime
Older
Cumberland Pharmaceuticals Inc (CPIX) (Q2 2026) Earnings Call Highlights: Strategic ...

Company closes $100M Apotex deal, declares special dividend, and advances key clinical programs including DMD, systemic sclerosis, and IPF.

GuruFocus.com
Cumberland Pharmaceuticals Q2 Earnings Call Highlights

Cumberland Pharmaceuticals (NASDAQ:CPIX) reported a second-quarter operating loss of $3.1 million as it prepared to transition from a commercial-stage specialty pharmaceutical company into an innovation-focused biopharmaceutical business following the sale of its branded U.S. commercial portfolio to

MarketBeat
ELTP vs. CPIX: Which Pharma Stock Is the Better Buy Right Now?

Elite Pharmaceuticals and Cumberland Pharmaceuticals follow different growth paths, but which looks more compelling now? Let's dive in.

Zacks
MMT Newswires
MMT Newswires
Zacks
Zacks
Zacks